A

APMD

APMD

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
67%Neutral
Buy/Sell Ratio100% buys
BearishBullish
APMD Live QuoteReal-time
$17.45
$1.06(-5.73%)1M
Day Range$17.41 – $19.06
Open$17.87
Previous Close$17.80
Volume297.6K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$741.03M
P/E Ratio (TTM)2.5
Forward P/ENaN
EPS (TTM)$7.22
Price to Book4.4
Dividend Yield0.65%
Beta (Volatility)1.18
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $17.45 (17%)
Low: $13.88High: $35.29
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$50.00-66.7% upside

Insider Buys

2

$5.20M

Insider Sales

0

$0

Total Volume

$5.20M

3 transactions

Net Activity

+$5.20M

Net buying

Proprietary Ratings
Calculated from Form 4 transactions
85CONFIDENCE

Sentiment Rating

Strong Accumulation

CEO Conviction Index

No Recent Signal

Key Drivers

  • •Strong buying bias: purchases represent 100% of total transaction value.
  • •Minor cluster buying: 2 unique insiders purchased shares.
  • •High accumulation: total purchase value exceeds $1M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
M
1

Multiple Insiders

P - Purchase Insiders

0 buys1 sells

$2258.86B total

M
2

Morningside Venture Investments Ltd

10%

1 buys0 sells

$5.00M total

S
3

Sekhri Paul J

Dir

1 buys0 sells

$200K total

Trading History
APMD insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Aug 3, 2026

3 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell7.23M$312500.00$2258.86B

Aug 3, 2026

3 months ago

Morningside Venture Investments Ltd

10%

10% Owner
Buy312.5K$16.00$5.00M

Aug 3, 2026

3 months ago

Sekhri Paul J

Dir

Director
Buy12.5K$16.00$200K
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
APMD Buy Conviction100%
Industry Rank#0 of 563
Volume Contribution0.0%
Total Industry Activity$16.73B

APMD has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for APMD

Over the last 90 days, corporate insiders at APMD (APMD) engaged in a total of 3 transactions reported via SEC Form 4 filings. Among these, 2 were open-market purchases and 0 were sales. The total volume of insider trading reached $5.20M.

The net insider activity for APMD shows a net buying bias of $5.20M. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 7.23M shares valued at $2258.86B on Aug 3, 2026.

Live Market News & Developments
Aggregated real-time headlines for APMD (APMD)
6 updates

Apnimed, Inc. (APMD) Stock Price, News, Quote & History

Yahoo! Finance Canada2d ago

Apnimed, Inc. (APMD) stock price, news, quote and history

Yahoo Finance UK3d ago

New National Survey Found Many People With Sleep Apnea Struggle to Stay on Treatment

Stock Titan4h ago

symbol__ Stock Quote Price and Forecast

CNN113d ago

APNIMED ($APMD) Releases Q3 2026 Earnings, Stock Rises

Quiver Quantitative2d ago

Apnimed, Inc. (APMD) stock price, news, quote and history

Yahoo Finance Singapore2d ago

FAQs About APMD Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for APMD.

Based on SEC Form 4 disclosures, the Insider Confidence Score for APMD is currently 85/100, which reflects a strong accumulation bias. This calculation accounts for a total of 2 purchases and 0 sales by company executives over the last 90 days.

The CEO Conviction Index for APMD is rated as "No Recent Signal". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.